A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.


Updates from The Motley Fool

Latest updates on Spectrum Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Spectrum Pharmaceuticals.


Stock Performance

View Interactive SPPI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Spectrum Pharmaceuticals.
Current Price: $10.43
Prev Close: $9.98
Open: $9.98
Bid: $10.34
Ask: $10.43
Day's Range: $9.74 - $10.58
52wk Range: $6.22 - $25.29
Volume: 939,139
Avg Vol 1,001,775
Market Cap: $1B
P/E (ttm): -8.60
EPS (ttm): -$1.16
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Spectrum Pharmaceuticals.
CAPS Rating 3 out of 5
 
419 Outperform
12 Underperform
CAPS All Stars
 
37 Outperform
2 Underperform

How do you think Spectrum Pharmaceuticals will perform against the market?



You pick for Spectrum Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph Turgeon, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Spectrum Pharmaceuticals.

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers